S-form lipopolysaccharide (LPS), but not lipid A or R-chemo-type LPS, induces interleukin-6 production in vitamin D3-differentiated THP-1 cells.
Bacterial lipopolysaccharide (LPS) induces the production of various inflammatory cytokines and the inducibility is considered attributable to the glycolipid part of LPS called lipid A. We report an in vitro model in which lipid A is not necessarily a minimal structure for the LPS activity. Vitamin D3-differentiated THP-1 cells, cultured human monocytic leukemia cells, produced a high level of interleukin-6 (IL-6) by stimulating LPS from Escherichia coli O111:B4, but not by stimulating synthetic E. coli-type lipid A (compound 506), E. coli Re mutant LPS (ReLPS), or alkali-treated LPS. The induction by LPS was inhibited by the anti-CD14 antibodies or by the synthetic lipid A precursor (compound 406). An alkali-treated LPS or compound 506 partially inhibited the LPS-induced IL-6 production. These facts suggest that lipid A alone is not sufficient for the IL-6-inducing activity, but the polysaccharide part in LPS contributes or acts as a co-factor for activation of differentiated THP-1 cells.
Suda
Y
Y
Graduate School of Science, Osaka University, Osaka, Toyonaka, 560-0043, Japan. ysuda@chem.sci.osaka-u.ac.jp
Aoyama
K
K
Arimoto
K
K
Tamura
T
T
Kusumoto
S
S
D000468:Alkalies / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001773:Blood Cells / Q000187:drug effects / Q000378:metabolism; D001798:Blood Proteins / Q000494:pharmacology; D002117:Calcitriol / Q000494:pharmacology*; D002448:Cell Adhesion / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006017:Glycolipids / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D015850:Interleukin-6 / Q000096:biosynthesis*; D008050:Lipid A / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology*; D018950:Lipopolysaccharide Receptors / Q000276:immunology / Q000502:physiology; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000494:pharmacology*; D009000:Monocytes / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D014407:Tumor Cells, Cultured
D000468:Alkalies; D000911:Antibodies, Monoclonal; D001798:Blood Proteins; D006017:Glycolipids; D015850:Interleukin-6; D008050:Lipid A; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; C085483:Re lipopolysaccharide; C040142:lipid A precursors, bacterial; D002117:Calcitriol